Insufficient scRNA-seq data for expression of CYP27B1 at single-cell level.
Insufficient scRNA-seq data for expression of CYP27B1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 434.81 | 328 / 328 | 96% | 3.39 | 170 / 178 |
lung | 97% | 154.95 | 558 / 578 | 97% | 8.59 | 1120 / 1155 |
thymus | 100% | 477.91 | 653 / 653 | 88% | 5.56 | 532 / 605 |
stomach | 88% | 69.84 | 315 / 359 | 94% | 4.12 | 268 / 286 |
bladder | 86% | 55.71 | 18 / 21 | 95% | 4.86 | 477 / 504 |
breast | 90% | 92.09 | 412 / 459 | 86% | 4.65 | 966 / 1118 |
skin | 98% | 144.51 | 1774 / 1809 | 76% | 2.77 | 360 / 472 |
adrenal gland | 100% | 372.89 | 258 / 258 | 67% | 2.06 | 154 / 230 |
intestine | 69% | 57.97 | 671 / 966 | 96% | 4.39 | 506 / 527 |
prostate | 93% | 85.91 | 227 / 245 | 69% | 1.52 | 348 / 502 |
kidney | 100% | 2180.12 | 89 / 89 | 61% | 2.68 | 546 / 901 |
uterus | 69% | 35.81 | 118 / 170 | 90% | 6.02 | 414 / 459 |
esophagus | 57% | 61.29 | 828 / 1445 | 97% | 5.32 | 177 / 183 |
ovary | 77% | 44.16 | 139 / 180 | 46% | 0.98 | 196 / 430 |
liver | 87% | 77.25 | 196 / 226 | 32% | 1.00 | 130 / 406 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.33 | 1 / 1 |
spleen | 94% | 50.65 | 226 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 7.98 | 42 / 45 |
brain | 53% | 24.40 | 1400 / 2642 | 40% | 5.16 | 281 / 705 |
lymph node | 0% | 0 | 0 / 0 | 90% | 31.14 | 26 / 29 |
adipose | 84% | 68.13 | 1006 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 63% | 38.67 | 844 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 39% | 0.61 | 31 / 80 |
muscle | 35% | 18.19 | 284 / 803 | 0% | 0 | 0 / 0 |
heart | 34% | 17.66 | 290 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 22% | 33.72 | 207 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0055074 | Biological process | calcium ion homeostasis |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0070314 | Biological process | G1 to G0 transition |
GO_0006766 | Biological process | vitamin metabolic process |
GO_0036378 | Biological process | calcitriol biosynthetic process from calciol |
GO_0043627 | Biological process | response to estrogen |
GO_0046697 | Biological process | decidualization |
GO_0010956 | Biological process | negative regulation of calcidiol 1-monooxygenase activity |
GO_0070564 | Biological process | positive regulation of vitamin D receptor signaling pathway |
GO_0030500 | Biological process | regulation of bone mineralization |
GO_0042369 | Biological process | vitamin D catabolic process |
GO_0010980 | Biological process | positive regulation of vitamin D 24-hydroxylase activity |
GO_0034341 | Biological process | response to type II interferon |
GO_0042359 | Biological process | vitamin D metabolic process |
GO_0030282 | Biological process | bone mineralization |
GO_0045618 | Biological process | positive regulation of keratinocyte differentiation |
GO_0006816 | Biological process | calcium ion transport |
GO_0033280 | Biological process | response to vitamin D |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0005739 | Cellular component | mitochondrion |
GO_0005737 | Cellular component | cytoplasm |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0004498 | Molecular function | calcidiol 1-monooxygenase activity |
GO_0062185 | Molecular function | secalciferol 1-monooxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0020037 | Molecular function | heme binding |
Gene name | CYP27B1 |
Protein name | 25-hydroxyvitamin D3-1alpha-hydroxylase (Cytochrome P450, family 27, subfamily B, polypeptide 1) Cytochrome P450 family 27 subfamily B member 1 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial (EC 1.14.15.18) (25-OHD-1 alpha-hydroxylase) (25-hydroxyvitamin D(3) 1-alpha-hydroxylase) (VD3 1A hydroxylase) (Calcidiol 1-monooxygenase) (Cytochrome P450 subfamily XXVIIB polypeptide 1) (Cytochrome P450C1 alpha) (Cytochrome P450VD1-alpha) (Cytochrome p450 27B1) |
Synonyms | CYP27B CYP1ALPHA |
Description | FUNCTION: A cytochrome P450 monooxygenase involved in vitamin D metabolism and in calcium and phosphorus homeostasis. Catalyzes the rate-limiting step in the activation of vitamin D in the kidney, namely the hydroxylation of 25-hydroxyvitamin D3/calcidiol at the C1alpha-position to form the hormonally active form of vitamin D3, 1alpha,25-dihydroxyvitamin D3/calcitriol that acts via the vitamin D receptor (VDR) . Has 1alpha-hydroxylase activity on vitamin D intermediates of the CYP24A1-mediated inactivation pathway . Converts 24R,25-dihydroxyvitamin D3/secalciferol to 1-alpha,24,25-trihydroxyvitamin D3, an active ligand of VDR. Also active on 25-hydroxyvitamin D2 . Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via FDXR/adrenodoxin reductase and FDX1/adrenodoxin . . |
Accessions | Q9UP42 ENST00000228606.9 O15528 V9GYP0 ENST00000546609.1 ENST00000546567.5 F8VWR7 |